From: Intricate role of intestinal microbe and metabolite in schizophrenia
Factors | Healthy group(n = 44) | Acute group (n = 41) | Remission group (n = 39) | F/t/χ2 | P |
---|---|---|---|---|---|
Age(years) | 42.61 ± 11.81 | 38.59 ± 11.25 | 39.74 ± 11.17 | 1.406 | 0.249 |
Sex(Males/Females) | Â | Â | Â | 2.363 | 0.307 |
 Males(proportion%) | 23(52.3) | 17(41.5) | 14(35.9) |  |  |
 Females(proportion%) | 21(47.7) | 24(58.5) | 25(64.1) |  |  |
BMI (kg/m2) | 22.68 ± 3.06 | 23.66 ± 2.78 | 23.85 ± 3.68 | 1.647 | 0.197 |
Years of education(years) | 10.44 ± 4.38 | 10.51 ± 4.38 | 9.72 ± 3.90 | 0.892 | 0.412 |
Course of disease(years) |  | 10.60 ± 7.49 | 13.01 ± 8.74 | -1.322 | 0.090 |
Drugs | Â | Â | Â | Â | Â |
 CPZ equivalent doses(mg) |  | 171.44 ± 121.68 | 227.99 ± 134.99 | -1.970 | 0.181 |
PANSS | Â | Â | Â | Â | Â |
 Positive symptom |  | 13.63 ± 6.05 | 9.56 ± 2.34 | 3.934 | 0.000 |
 Negative symptom |  | 17.90 ± 7.85 | 13.54 ± 4.23 | 3.071 | 0.014 |
 Cognitive defect symptom |  | 10.10 ± 3.53 | 6.69 ± 1.84 | 5.366 | 0.009 |
 Excited symptom |  | 10.15 ± 3.90 | 5.69 ± 1.10 | 6.091 | 0.000 |
 Depressive symptom |  | 4.07 ± 2.13 | 3.10 ± 0.68 | 2.721 | 0.001 |
 PANSS-Total |  | 73.07 ± 11.30 | 45.41 ± 6.82 | 7.279 | 0.002 |